Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 140 clinical trials
EGFR-targeted Therapy for Gastric Cancer

Based on targeted NGS panel results, metastatic gastric cancer patients with gene amplifications will receive either anti-EGFR antibody (GC-1118) in combination with weekly paclitaxel as a

  • 0 views
  • 24 May, 2021
  • 1 location
  • 0 views
  • 18 Nov, 2021
  • 1 location
Fight INflammation to Improve Outcome After Aneurysmal Subarachnoid HEmorRhage (FINISHER)

contributes to DCI and therefore poor outcome and plays a major role in SAH. Some studies suggest a beneficial effect of anti-inflammatory drugs like glucocorticoids (GC) in SAH patient, but there are no

  • 0 views
  • 03 Jun, 2022
  • 7 locations
Study on TIL for the Treatment of Advanced Breast Cancer

This study is to investigate the safety and efficacy of tumor infiltrating lymphocyte (TIL) therapy (GC 101 TIL) in patients with advanced breast cancer. Autologous TILs are expanded from tumor

cyclophosphamide
advanced breast cancer
metastasis
  • 0 views
  • 04 Oct, 2022
  • 1 location
MEthotrexate Versus TOcilizumab for Treatment of GIant Cell Arteritis: a Multicenter, Randomized, Controlled Trial (METOGiA)

> Glucocorticoids (GC) are the cornerstone of the treatment of GCA. They are very effective and are usually given for 18-24 months to avoid relapses. Therefore, most patients develop GC-related

glucocorticoids
polymyalgia
tocilizumab
prednisone
intermittent claudication
  • 4 views
  • 30 May, 2022
  • 1 location
Pharmacotoxicology of Trichloroethylene Metabolites: Kinetic Study of Dichloroacetate (DCA) in Persons Homozygous for KRT Versus Wildtype

DCA kinetics and biotransformation and 2) DCA's effects on tyrosine metabolism. Population pharmacogenetic analysis of MAAI allelic frequencies and GC or LC-MS/MS techniques for blood or

  • 67 views
  • 07 Nov, 2020
  • 1 location
GEN-001 in Combination With Avelumab for Patients With PD-L1 Positive Gastric Cancer

which is not received the Standard of Care (SOC) for patients with PD-L1 positive advanced GC/Gastroesophageal Junction Adenocarcinoma who are not received cancer immunotherapy regimens as mono or

adenocarcinoma
measurable disease
  • 0 views
  • 05 Jul, 2022
  • 5 locations
Alpelisib and Paclitaxel in PIK3CA-altered Gastric Cancer

PIK3CA mutations. In addition, alpelisib inhibited cell growth via G1 arrest and subsequently induces apoptosis in GC cells, and this effect is more remarkable in cells harboring PIK3CA mutations

human chorionic gonadotropin
cancer chemotherapy
metastatic gastric cancer
immunostimulants
measurable disease
  • 0 views
  • 01 Sep, 2021
  • 2 locations
PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores

American Men with Prostate Cancer: (VANDAAM)" that had high risk Decipher test results (Decipher score >0.45). Patients with a high genomic classifier (GC) score at diagnosis will be approached for

prostate cancer metastatic
prostatectomy
positron emission tomography
metastatic prostate cancer
  • 5 views
  • 04 Oct, 2022
  • 1 location
A Phase Ib/II Study of GT90001 Combined With KN046 in Solid Tumors

advanced or refractory hepatocellular carcinoma (HCC), gastric carcinoma (GC) and gastroesophageal junction (GEJ) adenocarcinoma, urothelial carcinoma (UC) and esophageal square cell carcinoma (ESCC).

  • 0 views
  • 18 Dec, 2021
  • 1 location